Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
BiomX Stock Could Soar 3000% As This $10M Biotech Cracks The 'Superbug' Code, Wall Street Says
Via News Direct
Exposures Product Safety
Tickers PHGE
Dr. Thomas John Byrne OBGYN Spotlighted for Lifelong Learning and Leadership in Women’s Health
Via Get News
Topics Product Recall
Exposures Legal Product Safety
HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial
Via Benzinga
Exposures Product Safety
Tickers OCGN
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ELTP
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
Via Benzinga
Topics Death
Exposures Death Product Safety
Tickers RHHBY SRPT
After 19 Explosions And Fire Injuries, Anker Recalls Over 1 Million Power Banks Sold Since 2016 — Is Yours Affected?
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
UroGen Pharma Stock Scores Bullish Price Target Revisions Up To $47 Following FDA Nod For Zusduri
Via Stocktwits
Exposures Product Safety
Tickers GS URGN
Sarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off Risk
Via Stocktwits
Exposures Product Safety
Tickers SRPT
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased
Via Stocktwits
Exposures Product Safety
Tickers AKRO GILD LLY PFE
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Reported Q1 2025 Results, Advanced Toward Commercialization Following VALID-ECG Study Success
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers BEAT
Why UroGen Pharma (URGN) Stock Is Skyrocketing This Week
Via Benzinga
Exposures Product Safety
Tickers URGN
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Via Benzinga
Exposures Product Safety
Tickers MLTX MRK
Merck Gets FDA Approval For Keytruda To Treat A Broader Population Of Head And Neck Cancer Patients: Retail Stays Bullish
Via Stocktwits
Topics Death
Exposures Death Product Safety
Tickers AMZN MRK VOO VTI
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst
Via Benzinga
Exposures Product Safety
Tickers ISRG MDT
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Via NewMediaWire
Exposures Product Safety
Tickers UNCY
Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers UNCY
GSK’s Application To European Authorities For Expanded Use Of RSV Vaccine In Younger Adults Fails To Rejuvenate Retail Optimism
Via Stocktwits
Exposures Product Safety
Tickers FVD GSK SPDW
Florida Fire Survivors Confront Growing Insurance Battles – Local Law Firm Mobilizes to Help Rebuild Lives and Secure Justice
Via AB Newswire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
SAPSOL Technologies Inc. Accelerates Zero-Blind-Spot Security with TraceSecure.ai – Phase 1 Live, AI Threat Engine Arriving 2026
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers MSFT SAP
FDA Approves UroGen's Zusduri As First Drug For Recurrent Bladder Cancer
Via Benzinga
Exposures Product Safety
Tickers URGN
UroGen Soars On Price Target Upgrade On Heels Of FDA Approval For Cancer Medicine: Retail Sees Stock Touching $20
Via Stocktwits
Exposures Product Safety
Tickers IWM IWO URGN
SalesPlastics.com Launches Global Platform for Polymer Resin Buyers and Industrial Manufacturers
Via Get News
Topics Supply Chain
Exposures Product Safety Supply Chain
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Jim Hunter to Board of Directors
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
Via Benzinga
Exposures Product Safety
Tickers GSK MRNA PFE
Uncover the sexy codes of women walking on the red carpet
Via 24-7 Press Release
Exposures Product Safety
Moderna’s RSV Vaccine Gets FDA Nod For Younger At-Risk Adults: Retail Stays Guarded Amid RFK Jr’s Immunization Shake-Up
Via Stocktwits
Topics Government
Exposures COVID-19 Political Product Safety
Tickers MRNA
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.